ReviewRSC advances2025
Recent trends in ionic liquid-mediated synthesis of thiazoles: toward greener methodologies.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Thiazoles inhibit reactive oxygen and nitrogen species mediated diabetes mellitus: integratedRSC advances · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thiazole moieties represent a vital category of heterocycles, offering versatile uses across drug development, agricultural formulations, and advanced materials. Nevertheless, conventional methods for their synthesis frequently depend on toxic solvents and rigorous conditions, which raise significant environmental and safety concerns. Recently, ionic liquids (ILs) have gained recognition as sustainable and versatile solvents due to their exceptional physico-chemical characteristics, namely minimal vapor pressure, adjustable polarity, and recyclability. This review focuses on synthesizing thiazole derivatives through ionic liquid-mediated strategies, emphasizing their alignment with the principles of green chemistry. Recent advancements in catalyst-free protocols and recyclable ionic liquid (IL) systems are discussed in detail, along with comparisons to conventional methods in terms of green metrics. This review integrates recent advancements to deliver a focused and thorough summary of green synthetic approaches for thiazoles between 2004 and 2025. It highlights the current limitations and proposes directions for future research toward greener and more scalable methodologies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.